ArticleNeuropsychiatric disease and treatment2018

Treatment patterns, health care resource utilization, and costs in Japanese adults with attention-deficit hyperactivity disorder treated with atomoxetine.

Hideyuki Imagawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.